Ironwood Pharmaceuticals, Inc. (IRWD) P/S ratio

P/S ratio today
2.7×

Ironwood Pharmaceuticals, Inc. (IRWD) trades at 2.7× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 1.9×. That is 8.1% lower than the 2.0× of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
2.7×
P/S ratio, fiscal 2025
1.9×
Change on fiscal 2024
−8.1%
Highest on record
21.2×fiscal 2010
Lowest on record
1.9×fiscal 2025
Fiscal years on record
102010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ironwood Pharmaceuticals, Inc. P/S ratio, in more detail

Today's figure is 44.5% above the fiscal 2025 year-end.

Across the 10 fiscal year-ends on record (2010–2025), the highest was 21.2× in fiscal 2010 and the lowest 1.9× in fiscal 2025. Today's P/S ratio is higher than at 20% of the 10 fiscal year-ends on record; their median is 4.7×.

History · 10 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Ironwood Pharmaceuticals, Inc. P/S ratio, year by year

Ironwood Pharmaceuticals, Inc. (IRWD) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today2.7×—$4.87—
20251.9× 8.1% down$3.37$1.82
20242.0× 49.8% down$4.43$2.20
20234.0× 28.6% down$11.44$2.85
20225.6× 21.3% up$12.39$2.20
20214.6× 1.4% down$11.66$2.52
20204.7× 3.1% down$11.39$2.42
20194.8× 26.9% up$13.31$2.75
20183.8×—$8.68$2.27
2017——$12.55—
2016——$12.81—
2015——$9.71—
2014——$12.83—
2013——$9.72—
2012——$9.28—
201118.1× 14.2% down$10.03$0.55
201021.2×—$8.67$0.41
2009———$4.04

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. P/S ratio: questions and answers

What is Ironwood Pharmaceuticals, Inc.'s P/S ratio?

Ironwood Pharmaceuticals, Inc. (IRWD) trades at 2.7× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 1.9×. That is 8.1% lower than the 2.0× of fiscal 2024.

Is Ironwood Pharmaceuticals, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 20% of the 10 fiscal year-ends on record; their median is 4.7×.

What are the highest and lowest P/S ratio figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 10 fiscal year-ends on record (2010–2025), the highest was 21.2× in fiscal 2010 and the lowest 1.9× in fiscal 2025.

How is Ironwood Pharmaceuticals, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Ironwood Pharmaceuticals, Inc. it is on record here for 10 fiscal years, 2010 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.